247 related articles for article (PubMed ID: 22155627)
1. Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo.
Babaei E; Sadeghizadeh M; Hassan ZM; Feizi MA; Najafi F; Hashemi SM
Int Immunopharmacol; 2012 Jan; 12(1):226-34. PubMed ID: 22155627
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of dendrosomal curcumin on an animal metastatic breast tumor.
Farhangi B; Alizadeh AM; Khodayari H; Khodayari S; Dehghan MJ; Khori V; Heidarzadeh A; Khaniki M; Sadeghiezadeh M; Najafi F
Eur J Pharmacol; 2015 Jul; 758():188-96. PubMed ID: 25863259
[TBL] [Abstract][Full Text] [Related]
3. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
Dorai T; Cao YC; Dorai B; Buttyan R; Katz AE
Prostate; 2001 Jun; 47(4):293-303. PubMed ID: 11398177
[TBL] [Abstract][Full Text] [Related]
6. Tehranolide molecule modulates the immune response, reduce regulatory T cell and inhibits tumor growth in vivo.
Noori S; Taghikhani M; Hassan ZM; Allameha A; Mostafaei A
Mol Immunol; 2010 Apr; 47(7-8):1579-84. PubMed ID: 20138670
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts.
Perry MC; Demeule M; Régina A; Moumdjian R; Béliveau R
Mol Nutr Food Res; 2010 Aug; 54(8):1192-201. PubMed ID: 20087857
[TBL] [Abstract][Full Text] [Related]
8. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits WEHI-3 leukemia cells in BALB/c mice in vivo.
Su CC; Yang JS; Lin SY; Lu HF; Lin SS; Chang YH; Huang WW; Li YC; Chang SJ; Chung JG
In Vivo; 2008; 22(1):63-8. PubMed ID: 18396784
[TBL] [Abstract][Full Text] [Related]
10. Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment.
Shiri S; Alizadeh AM; Baradaran B; Farhanghi B; Shanehbandi D; Khodayari S; Khodayari H; Tavassoli A
Asian Pac J Cancer Prev; 2015; 16(9):3917-22. PubMed ID: 25987060
[TBL] [Abstract][Full Text] [Related]
11. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.
Mohanty C; Sahoo SK
Biomaterials; 2010 Sep; 31(25):6597-611. PubMed ID: 20553984
[TBL] [Abstract][Full Text] [Related]
12. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells.
Tahmasebi Mirgani M; Isacchi B; Sadeghizadeh M; Marra F; Bilia AR; Mowla SJ; Najafi F; Babaei E
Int J Nanomedicine; 2014; 9():403-17. PubMed ID: 24531649
[TBL] [Abstract][Full Text] [Related]
13. Naloxone can improve the anti-tumor immunity by reducing the CD4+CD25+Foxp3+ regulatory T cells in BALB/c mice.
Molla Hassan AT; Hassan ZM; Moazzeni SM; Mostafaie A; Shahabi S; Ebtekar M; Hashemi SM
Int Immunopharmacol; 2009 Nov; 9(12):1381-6. PubMed ID: 19706340
[TBL] [Abstract][Full Text] [Related]
14. Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo.
Schaaf C; Shan B; Buchfelder M; Losa M; Kreutzer J; Rachinger W; Stalla GK; Schilling T; Arzt E; Perone MJ; Renner U
Endocr Relat Cancer; 2009 Dec; 16(4):1339-50. PubMed ID: 19726538
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferation and anti-angiogenesis of curcumin-K30 solid dispersion.
Chen C; Huang X; Cai H; Xu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 35(10):1029-36. PubMed ID: 21051827
[TBL] [Abstract][Full Text] [Related]
16. PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells.
Al-Hujaily EM; Mohamed AG; Al-Sharif I; Youssef KM; Manogaran PS; Al-Otaibi B; Al-Haza'a A; Al-Jammaz I; Al-Hussein K; Aboussekhra A
Breast Cancer Res Treat; 2011 Jul; 128(1):97-107. PubMed ID: 20680677
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo.
Phillips JM; Clark C; Herman-Ferdinandez L; Moore-Medlin T; Rong X; Gill JR; Clifford JL; Abreo F; Nathan CO
Otolaryngol Head Neck Surg; 2011 Jul; 145(1):58-63. PubMed ID: 21493306
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anti-tumor effects of tumor cell lysate enriched by HSP-70 against fibrosarcoma tumor in BALB/c mice.
Hashemi SM; Hassan ZM; Soudi S; Ghazanfari T; Kheirandish M; Shahabi S
Int Immunopharmacol; 2007 Jul; 7(7):920-7. PubMed ID: 17499194
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B
Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
